Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00896285 · ClinicalTrials.gov registry record · NA
The First Therapeutic Intervention in Malignant Pleural Effusion Trial
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT00896285: Completed NA study, sponsored by University of California, Davis.
NCT00896285 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00896285, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
Fluid caused by cancer cells may accumulate in the lining of the lung. Draining the fluid with a chest tube may relieve pain and shortness of breath. To stop the fluid from coming back again, patients are given a medicine (talc) into the chest drain to seal up the space around the lung. This procedure is known as pleurodesis. This sometimes causes pain and discomfort, and the investigators do not know the best way of preventing this. The investigators hope to find the best way to prevent pain during pleurodesis.
Interventions
- OTHER Large bore chest drain + NSAID based analgesic regimen
- OTHER Small bore chest drain + NSAID based analgesic regimen
- OTHER Large bore chest drain + opiate based analgesic regimen
- OTHER Small bore chest drain + opiate based analgesic regimen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2009-04 |
| Est. Completion | 2014-12 |
| Phase | NA |
What the finished NCT00896285 record still lists
NCT00896285 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 4 interventions - of which Large bore chest drain + NSAID based analgesic regimen is the first listed.
NCT00896285 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00896285 about?
NCT00896285 is a clinical study titled "The First Therapeutic Intervention in Malignant Pleural Effusion Trial". Fluid caused by cancer cells may accumulate in the lining of the lung. Draining the fluid with a chest tube may relieve pain and shortness of breath. To stop the fluid from coming back again, patients are given a medicine (talc) into the chest drain to seal up the space around the lung. This procedu...
What is the current status of trial NCT00896285?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2009-04. Estimated completion is 2014-12.
What interventions are being tested in trial NCT00896285?
The interventions under investigation include: Large bore chest drain + NSAID based analgesic regimen (OTHER), Small bore chest drain + NSAID based analgesic regimen (OTHER), Large bore chest drain + opiate based analgesic regimen (OTHER), Small bore chest drain + opiate based analgesic regimen (OTHER).
Who is sponsoring clinical trial NCT00896285?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00896285's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia